LAB
Standard BioTools Inc. · Healthcare
Caligan Partners LP bought $527K of Standard BioTools Inc.
10% owner
Bought$526,608
$1.75Price
301,182Shares
+1%Stake
What LAB did for a copier
Prices for LAB after this filing aren't in yet.
Caligan Partners LP's record
6 other buys with 3 months of prices since 2022: on average +23.2% against the S&P 500, and 5 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Aug 3. Filed Fri, Aug 5, 7:10 AM ET, before the open. Not investment advice.